Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hod Hasharon, Israel Clinical Trials

A listing of Hod Hasharon, Israel clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Prediction of SSRI Treatment in Major Depression.

Major depression is a mood disorder affecting 350 million people worldwide. The disorder is characterized by depressed mood, anhedonia, decreased quality of life, deficits in cognitive functions and even suicide thoughts. Treatment of depression is often a long process and includes taking different types and quantities of medications. Therefore, there ...

Phase N/A

6.61 miles

Learn More »

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

Phase

6.61 miles

Learn More »

The Influence of Vestibular Stimulation on Cardiac Autonomic Control System in Subjects With and Without BPPV

This is a case-control study, that will consist of one routine assessment by a vestibular physiotherapist in an outpatient clinic in Tel Aviv ("Clalit Health Services"). The session will last approximately 90 minutes, and will include 40-60 participants. Two groups of patients (30-70 years old) will be assigned to this ...

Phase N/A

7.46 miles

Learn More »

Digital Wearable Walking Aid for Freezing of Gait in Parkinson s Disease

The objective of this study is to investigate the effects of relatively long-term use of a wearable device that provides personalized and intelligent cues (e.g. only when FOG is detected) on FOG. It is hypothesized that the use of this device will reduce FOG in the home and in the ...

Phase N/A

7.46 miles

Learn More »

Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients

This study is designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic efficacy of treatment with either VAY736 or CFZ533 in patients with SLE to enable further development of these compounds as treatment in this disease population

Phase

8.07 miles

Learn More »